RecruitingNCT04457544

Spontaneous Coronary Artery Dissection National Swiss Registry

Spontaneous Coronary Artery Dissection (SCAD) National Swiss Registry (SwissSCAD)

Sponsor

Dr. Sophie Degrauwe

Enrollment

1,000 participants

Start Date

Aug 12, 2020

Study Type

OBSERVATIONAL

Conditions

Spontaneous Coronary Artery Dissection

Summary

Spontaneous coronary artery dissection (SCAD), is an underdiagnosed pathology, affecting predominantly young women without traditional cardiovascular risk factors and is associated with major adverse outcomes including myocardial infarction, cardiac arrest, or death. Timely diagnosis of SCAD as well as clinical follow-up are of the essence in this pathology associated with major cardiac adverse outcomes. Despite recent improvements in diagnosis and recognition of the importance of SCAD, it remains poorly studied and understood. In this context, we designed the SwissSCAD registry, a large, observational, prospective, cohort study, to describe the natural history of SCAD, its outcomes and its treatments.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is a national Swiss registry for patients diagnosed with spontaneous coronary artery dissection (SCAD) — a rare but life-threatening cause of heart attack, particularly in younger women, where the inner wall of a coronary artery tears spontaneously (not due to plaque buildup). Because SCAD is rare and poorly understood, gathering data from many patients is crucial to understanding how it presents, what treatments work, and how to prevent recurrence. The registry collects detailed information on patients newly diagnosed with SCAD or diagnosed within the past 5 years. You may be eligible if: - You are 18 years of age or older - You have been newly diagnosed with SCAD, or were diagnosed within the last 5 years - You are willing to sign informed consent You may NOT be eligible if: - You are unwilling or unable to provide informed consent - Your coronary dissection was caused by atherosclerosis (plaque buildup) or a medical procedure (iatrogenic) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.